Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synsam ABOSTO:SYNSAM +0.53%85 FCF Margin % is 16.75% as of Mar. 2026, which is 19% above its 10-year median of 14.08. GuruFocus rates OSTO:SYNSAM with a GF Score™ of 85/100 and a GF Value™ of kr61.30 (Fairly Valued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Synsam AB ranks better than 84.05% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Synsam AB's Free Cash Flow for the
three
months ended in Mar. 2026 was kr297 Mil. Synsam AB's Revenue for the
three
months ended in Mar. 2026 was kr1,773 Mil. Therefore, Synsam AB's FCF Margin % for the quarter that ended in Mar. 2026 was 16.75%.
The historical rank and industry rank for Synsam AB's FCF Margin % or its related term are showing as below:
OSTO:SYNSAM'
s FCF Margin % Range Over the Past 10 Years
Min: 5.76 Med: 14.08 Max: 19.12
Current: 14.39
During the past 8 years, the highest FCF Margin % of Synsam AB was 19.12%. The lowest was 5.76%. And the median was 14.08%.
OSTO:SYNSAM's FCF Margin % is ranked better than 84.05% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.64
vs OSTO:SYNSAM: 14.39
The historical data trend for Synsam AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SYNSAM vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Synsam AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synsam AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Synsam AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synsam AB (OSTO:SYNSAM) has a FCF Margin % of 16.75% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Synsam AB and its competitors. This is 19% above median its historical median of 14.08. Over the past decade, Synsam AB's FCF Margin % has ranged from 5.76 to 19.12. According to the industry distribution chart, Synsam AB ranks #130 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 16%.
Is Synsam AB's FCF Margin % too high?
Synsam AB's current FCF Margin % of 16.75% is 19% above median its 10-year median of 14.08. Over the past 10 years, this metric has ranged from a low of 5.76 to a high of 19.12. Based on the distribution chart, Synsam AB ranks #130 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Synsam AB has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #130 out of 815 companies for FCF Margin %. This places Synsam AB in the top 16% of its industry — outperforming the majority of peers. Historically, Synsam AB's own FCF Margin % has ranged from 5.76 to 19.12 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Synsam AB and its competitors. Synsam AB's current FCF Margin % is 16.75%, which is 19% above median its own 10-year median of 14.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Based on GuruFocus' analysis, Synsam AB (OSTO:SYNSAM) is currently considered Fairly Valued. The stock's GF Value™ is kr61.30, compared to a current price of kr56.80 — trading 7.3% below its estimated fair value. The current FCF Margin % is 16.75%, which is 19% above median its 10-year median of 14.08. Synsam AB's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Synsam AB (OSTO:SYNSAM), the current FCF Margin % is 16.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synsam AB (OSTO:SYNSAM) Overvalued in 2026?
Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued.
The current stock price of kr56.80 is trading 7.3% below its estimated GF Value™ of kr61.30.
GuruFocus considers Synsam AB to be Fairly Valued.
Key valuation signals for OSTO:SYNSAM:
FCF Margin %: 16.75% (19% above median its 10-year median of 14.08)
GF Value™: kr61.30 vs. price of kr56.80 (7.3% below fair value)
No single metric tells the full story. See the OSTO:SYNSAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
85GF Score
Get the complete analysis for OSTO:SYNSAM
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SYNSAM has been successfully added to your 
